Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Darya-Varia Laboratoria Tbk PT
IDX:DVLA
Price:
1 615
IDR
-0.31%
Market Closed
Market Cap:
1.8T
IDR
Add
Note
Why Create Notes?
Capture your thoughts
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Peter Lynch
Track and Analyze Performance
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Continuous Learning and Adaptation
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
Boost Decision Confidence
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Delete Note
Do you really want to delete this note?
This action cannot be undone.
DVLA Alert
Darya-Varia Laboratoria Tbk PT
1615
-5 (-0.31%)
| 52 Week Range |
1 390
1 810
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
Delete Alert
This alert will be permanently deleted.
Ask me anything about
Darya-Varia Laboratoria Tbk PT
Income Statement
Earnings Waterfall
Darya-Varia Laboratoria Tbk PT
Darya-Varia Laboratoria Tbk PT
|
Revenue
|
2.1T
IDR
|
|
Cost of Revenue
|
-1T
IDR
|
|
Gross Profit
|
1.1T
IDR
|
|
Operating Expenses
|
-872.2B
IDR
|
|
Operating Income
|
252.6B
IDR
|
|
Other Expenses
|
-58.7B
IDR
|
|
Net Income
|
193.9B
IDR
|
Income Statement
Darya-Varia Laboratoria Tbk PT
Darya-Varia Laboratoria Tbk PT
Currency: IDR
| Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||||||||
| Revenue |
1 073 326
N/A
|
1 103 822
+3%
|
1 228 852
+11%
|
1 290 566
+5%
|
1 269 185
-2%
|
1 306 098
+3%
|
1 343 054
+3%
|
1 399 810
+4%
|
1 472 526
+5%
|
1 451 357
-1%
|
1 470 354
+1%
|
1 479 646
+1%
|
1 515 074
+2%
|
1 575 647
+4%
|
1 607 717
+2%
|
1 597 357
-1%
|
1 598 083
+0%
|
1 699 657
+6%
|
1 750 914
+3%
|
1 799 139
+3%
|
1 875 188
+4%
|
1 813 020
-3%
|
1 814 913
+0%
|
1 827 255
+1%
|
1 680 412
-8%
|
1 829 700
+9%
|
1 834 423
+0%
|
1 876 676
+2%
|
2 120 581
+13%
|
1 900 894
-10%
|
2 058 892
+8%
|
2 009 621
-2%
|
1 856 945
-8%
|
1 917 041
+3%
|
1 783 948
-7%
|
1 815 693
+2%
|
1 739 189
-4%
|
1 890 888
+9%
|
1 910 016
+1%
|
1 995 668
+4%
|
2 134 031
+7%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
(499 144)
|
(518 192)
|
(576 212)
|
(622 053)
|
(611 025)
|
(628 365)
|
(641 066)
|
(667 070)
|
(694 875)
|
(649 919)
|
(627 912)
|
(608 938)
|
(621 959)
|
(681 691)
|
(706 517)
|
(717 212)
|
(726 101)
|
(774 248)
|
(803 530)
|
(823 283)
|
(857 061)
|
(839 538)
|
(870 012)
|
(868 819)
|
(816 100)
|
(897 711)
|
(891 946)
|
(928 977)
|
(1 010 366)
|
(905 125)
|
(966 053)
|
(929 159)
|
(885 273)
|
(910 918)
|
(872 726)
|
(891 329)
|
(858 646)
|
(915 648)
|
(911 441)
|
(963 160)
|
(1 009 196)
|
|
| Gross Profit |
574 182
N/A
|
585 630
+2%
|
652 643
+11%
|
668 515
+2%
|
658 162
-2%
|
677 733
+3%
|
701 988
+4%
|
732 740
+4%
|
777 651
+6%
|
801 438
+3%
|
842 442
+5%
|
870 708
+3%
|
893 115
+3%
|
893 956
+0%
|
901 200
+1%
|
880 145
-2%
|
871 982
-1%
|
925 410
+6%
|
947 385
+2%
|
975 856
+3%
|
1 018 127
+4%
|
973 482
-4%
|
944 901
-3%
|
958 436
+1%
|
864 312
-10%
|
931 989
+8%
|
942 478
+1%
|
947 699
+1%
|
1 110 215
+17%
|
995 768
-10%
|
1 092 839
+10%
|
1 080 462
-1%
|
971 672
-10%
|
1 006 123
+4%
|
911 222
-9%
|
924 363
+1%
|
880 543
-5%
|
975 240
+11%
|
998 575
+2%
|
1 032 508
+3%
|
1 124 835
+9%
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(448 356)
|
(484 922)
|
(463 798)
|
(528 467)
|
(529 731)
|
(555 918)
|
(578 506)
|
(597 207)
|
(589 947)
|
(596 388)
|
(603 206)
|
(613 899)
|
(638 052)
|
(673 953)
|
(707 804)
|
(682 806)
|
(676 210)
|
(665 429)
|
(652 388)
|
(693 180)
|
(718 148)
|
(668 230)
|
(691 653)
|
(641 214)
|
(622 386)
|
(722 627)
|
(699 529)
|
(747 361)
|
(746 809)
|
(796 909)
|
(814 003)
|
(826 506)
|
(904 516)
|
(812 823)
|
(812 336)
|
(817 292)
|
(758 952)
|
(782 930)
|
(800 178)
|
(820 348)
|
(872 197)
|
|
| Selling, General & Administrative |
(418 832)
|
(452 114)
|
(427 745)
|
(487 429)
|
(496 893)
|
(520 011)
|
(541 450)
|
(561 377)
|
(556 150)
|
(555 843)
|
(561 023)
|
(566 883)
|
(588 695)
|
(632 944)
|
(668 096)
|
(646 247)
|
(637 849)
|
(625 858)
|
(609 637)
|
(648 274)
|
(671 579)
|
(624 310)
|
(642 965)
|
(586 033)
|
(565 172)
|
(640 058)
|
(615 837)
|
(661 046)
|
(665 420)
|
(695 276)
|
(710 351)
|
(724 272)
|
(785 413)
|
(732 012)
|
(744 759)
|
(753 172)
|
(713 423)
|
(701 176)
|
(704 956)
|
(716 894)
|
(751 180)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(5 739)
|
(10 877)
|
(16 040)
|
(26 303)
|
(17 847)
|
(18 363)
|
(19 489)
|
(40 300)
|
(37 042)
|
(36 753)
|
(42 591)
|
(25 013)
|
(24 981)
|
(27 676)
|
(23 537)
|
(30 658)
|
(33 097)
|
(36 953)
|
(38 336)
|
|
| Depreciation & Amortization |
(12 390)
|
(13 000)
|
(13 646)
|
(14 064)
|
(14 313)
|
(14 327)
|
(14 424)
|
(14 486)
|
(14 419)
|
(16 599)
|
(18 645)
|
(20 708)
|
(22 879)
|
(23 031)
|
(23 365)
|
(23 772)
|
(24 256)
|
(24 561)
|
(24 669)
|
(25 421)
|
(26 168)
|
(26 989)
|
(28 758)
|
(29 907)
|
(30 861)
|
(28 870)
|
(27 923)
|
(27 092)
|
(26 793)
|
(33 113)
|
(30 091)
|
(31 081)
|
(31 988)
|
(30 511)
|
(32 170)
|
(31 760)
|
(31 177)
|
(32 829)
|
(33 968)
|
(33 737)
|
(36 425)
|
|
| Other Operating Expenses |
(17 134)
|
(19 808)
|
(22 407)
|
(26 975)
|
(18 527)
|
(21 580)
|
(22 631)
|
(21 345)
|
(19 380)
|
(23 946)
|
(23 540)
|
(26 309)
|
(26 478)
|
(17 978)
|
(16 344)
|
(12 788)
|
(14 107)
|
(15 011)
|
(18 083)
|
(19 484)
|
(20 400)
|
(16 931)
|
(14 191)
|
(14 396)
|
(10 312)
|
(27 397)
|
(37 922)
|
(40 861)
|
(35 107)
|
(28 220)
|
(36 518)
|
(34 400)
|
(44 524)
|
(25 286)
|
(10 426)
|
(4 685)
|
9 184
|
(18 267)
|
(28 157)
|
(32 764)
|
(46 256)
|
|
| Operating Income |
125 826
N/A
|
100 707
-20%
|
188 844
+88%
|
140 047
-26%
|
128 430
-8%
|
121 816
-5%
|
123 482
+1%
|
135 534
+10%
|
187 705
+38%
|
205 050
+9%
|
239 236
+17%
|
256 809
+7%
|
255 063
-1%
|
220 003
-14%
|
193 397
-12%
|
197 340
+2%
|
195 772
-1%
|
259 981
+33%
|
294 996
+13%
|
282 677
-4%
|
299 979
+6%
|
305 252
+2%
|
253 248
-17%
|
317 222
+25%
|
241 926
-24%
|
209 361
-13%
|
242 949
+16%
|
200 338
-18%
|
363 406
+81%
|
198 859
-45%
|
278 836
+40%
|
253 956
-9%
|
67 157
-74%
|
193 301
+188%
|
98 886
-49%
|
107 071
+8%
|
121 590
+14%
|
192 309
+58%
|
198 397
+3%
|
212 160
+7%
|
252 638
+19%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
11 579
|
14 292
|
22 244
|
21 751
|
26 210
|
26 854
|
23 454
|
21 562
|
18 558
|
13 383
|
11 042
|
12 031
|
7 874
|
7 727
|
9 746
|
14 284
|
20 371
|
13 920
|
5 987
|
(3 634)
|
(8 764)
|
(3 061)
|
13 870
|
11 572
|
13 791
|
6 066
|
5 025
|
7 175
|
4 350
|
12 302
|
1 732
|
5 450
|
8 941
|
7 266
|
3 121
|
(574)
|
(2 007)
|
(3 707)
|
1 645
|
5 526
|
563
|
|
| Non-Reccuring Items |
3 743
|
(5 346)
|
(5 351)
|
(8 973)
|
(8 995)
|
208
|
175
|
251
|
(183)
|
(1 320)
|
(1 348)
|
(1 458)
|
(807)
|
(37)
|
(21)
|
0
|
121
|
327
|
791
|
583
|
129
|
215
|
(91)
|
71
|
(531)
|
(500)
|
(597)
|
(546)
|
492
|
1 179
|
1 241
|
1 553
|
1 586
|
1 230
|
1 587
|
1 884
|
2 324
|
3 450
|
3 737
|
4 269
|
4 908
|
|
| Total Other Income |
(1)
|
(2 896)
|
(2 897)
|
(2 897)
|
(2 898)
|
(4 441)
|
(5 794)
|
(6 353)
|
(6 710)
|
(2 696)
|
(1 847)
|
(1 684)
|
(1 560)
|
(1 545)
|
(1 518)
|
(1 554)
|
(1 555)
|
(1 384)
|
(1 117)
|
(686)
|
(1 082)
|
(1 157)
|
(1 515)
|
(1 661)
|
(1 203)
|
(858)
|
(634)
|
(663)
|
(727)
|
(829)
|
(920)
|
(906)
|
(893)
|
(724)
|
(607)
|
(545)
|
(447)
|
(414)
|
(385)
|
(486)
|
(622)
|
|
| Pre-Tax Income |
141 147
N/A
|
106 757
-24%
|
202 840
+90%
|
149 928
-26%
|
142 747
-5%
|
144 438
+1%
|
141 317
-2%
|
150 994
+7%
|
199 369
+32%
|
214 417
+8%
|
247 081
+15%
|
265 696
+8%
|
260 569
-2%
|
226 148
-13%
|
201 603
-11%
|
210 070
+4%
|
214 710
+2%
|
272 844
+27%
|
300 656
+10%
|
278 940
-7%
|
290 261
+4%
|
301 250
+4%
|
265 511
-12%
|
327 205
+23%
|
253 983
-22%
|
214 069
-16%
|
246 742
+15%
|
206 305
-16%
|
367 522
+78%
|
211 511
-42%
|
280 888
+33%
|
260 053
-7%
|
76 792
-70%
|
201 073
+162%
|
102 988
-49%
|
107 835
+5%
|
121 460
+13%
|
191 638
+58%
|
203 394
+6%
|
221 469
+9%
|
257 487
+16%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||||||||
| Tax Provision |
(32 595)
|
(25 160)
|
(43 983)
|
(41 261)
|
(41 247)
|
(36 543)
|
(36 684)
|
(37 001)
|
(51 836)
|
(62 334)
|
(68 000)
|
(75 943)
|
(73 498)
|
(63 899)
|
(60 078)
|
(60 589)
|
(61 597)
|
(72 192)
|
(79 649)
|
(72 824)
|
(75 275)
|
(79 467)
|
(70 455)
|
(80 229)
|
(62 483)
|
(51 996)
|
(60 227)
|
(49 878)
|
(84 679)
|
(65 006)
|
(78 072)
|
(77 313)
|
(32 837)
|
(51 698)
|
(29 713)
|
(31 482)
|
(37 559)
|
(45 302)
|
(50 483)
|
(52 087)
|
(63 581)
|
|
| Income from Continuing Operations |
108 551
|
81 598
|
158 858
|
108 668
|
101 501
|
107 894
|
104 633
|
113 993
|
147 533
|
152 083
|
179 082
|
189 754
|
187 072
|
162 249
|
141 526
|
149 482
|
153 114
|
200 652
|
221 007
|
206 116
|
214 986
|
221 783
|
195 056
|
246 976
|
191 500
|
162 073
|
186 516
|
156 427
|
282 843
|
146 505
|
202 817
|
182 740
|
43 955
|
149 375
|
73 275
|
76 354
|
83 901
|
146 336
|
152 911
|
169 381
|
193 905
|
|
| Net Income (Common) |
108 551
N/A
|
81 598
-25%
|
158 858
+95%
|
108 668
-32%
|
101 501
-7%
|
107 894
+6%
|
104 633
-3%
|
113 993
+9%
|
147 533
+29%
|
152 083
+3%
|
179 082
+18%
|
189 754
+6%
|
187 072
-1%
|
162 249
-13%
|
141 526
-13%
|
149 482
+6%
|
153 114
+2%
|
200 652
+31%
|
221 007
+10%
|
206 116
-7%
|
214 986
+4%
|
221 783
+3%
|
195 056
-12%
|
246 976
+27%
|
191 500
-22%
|
162 073
-15%
|
186 516
+15%
|
156 427
-16%
|
282 843
+81%
|
146 505
-48%
|
202 817
+38%
|
182 740
-10%
|
43 955
-76%
|
149 375
+240%
|
73 275
-51%
|
76 354
+4%
|
83 901
+10%
|
146 336
+74%
|
152 911
+4%
|
169 381
+11%
|
193 905
+14%
|
|
| EPS (Diluted) |
96.92
N/A
|
73.12
-25%
|
142.34
+95%
|
97.37
-32%
|
90.95
-7%
|
96.69
+6%
|
93.75
-3%
|
102.14
+9%
|
132.19
+29%
|
136.28
+3%
|
160.48
+18%
|
170.04
+6%
|
167.63
-1%
|
145.39
-13%
|
126.81
-13%
|
133.94
+6%
|
137.2
+2%
|
179.8
+31%
|
198.03
+10%
|
184.09
-7%
|
192.19
+4%
|
198.24
+3%
|
174.24
-12%
|
220.41
+26%
|
170.98
-22%
|
144.71
-15%
|
166.53
+15%
|
139.67
-16%
|
252.54
+81%
|
130.81
-48%
|
181.09
+38%
|
163.16
-10%
|
39.25
-76%
|
133.37
+240%
|
65.42
-51%
|
68.17
+4%
|
74.91
+10%
|
130.66
+74%
|
135.94
+4%
|
151.23
+11%
|
173.12
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
You don't have any saved screeners yet
